Cipla to market BioQuiddity's products in EU

Cipla is up 3 percent, followed by Tata Steel, Reliance, Coal India and GAIL. Hindalco, Wipro, MM, Dr Reddy's Labs and Sun Pharma are among the laggards.

It's earnings season. www.indiainfoline.com, a part of the IIFL Group, presents you real-time, comprehensive, and in-depth analysis of company earnings to give you that investment edge. The 'Results Calendar' helps you keep track of all important results. The ...

Cipla held on to its firm undertone at the close of trading on the NSE on Thursday. It finished the day at ₹456.30, up 1.92 per cent on its previous close at ₹447.70. Tata Steel was firm but off its morning highs at ₹553.40. This represented ...

Arun Gupta, global Chief Information Officer of Cipla, after spending more than 2 years with the pharma giant, has decided to move on. Thursday will be Gupta's last day in office. His next destination is still unknown. Speaking to ETCIO, Gupta ...

Lupin, Dr Reddy's Lab, Cadila Healthcare, Torrent Pharma, Ipca Lab, Cipla and Wockhardt are up 1-5% on NSE.

Cipla marked his second stint in the Pharma vertical News | by CIOL Bureau MUMBAI, INDIA: Industry veteran, and CIO at Cipla , Arun Gupta has decided to move on to new contours now. A little birdie tells us thatThursday July ...

Cipla and F. Hoffmann-La Roche are in talks to settle the Tarceva patent infringement case that dates back to 2008. Photo: S. Kumar/Mint Mumbai: Indian generics or copycat drug makers and multinational pharma companies are increasingly resorting ...

Details Category: Latest Updates Published on Friday, 25 July 2014 14:00 He was the Chairman of McKinsey India Cipla has appointed Adil Zainulbhai as an independent director on the Board. Zainulbhai retired as Chairman of McKinsey ...

@Cipla_Limited1 Limited, through its wholly owned subsidiary @Meditab Private Limited has hiked its stake to 100% in Goa based biotech firm Mabpharm Private Limited for an undisclosed amount. Cipla previously held 25% stake in the company and with ...